baber/WOPTO huggingface dataset:
Patent AU-2240383-A (AU)
Title: Reinforcing rod holder
IPC: E04G21/12
Filed: 1983-12-14
Abstract: The reinforcing rod holder includes a hollow body (1) having a depression in which the downwardly bent reinforcing rods (2) are inserted in such a manner that their U-shaped anchoring portions protrude. The free end (3 and 4) of the reinforcing rods are disposed entirely in the hollow body, together with the bend portion. To permit insertion of the anchoring portions, the hollow body is provided with apertures (5), and holes (6) having a diameter which is approximately identical to the diameter of the reinforcing rods are provided at the two ends of such apertures (5), while the central portion of the apertures is sealed by two overlapping flaps (7). The hollow body is further provided with mounting or support ribs (8) at the apertures (5) and two spacer ribs (9 and 10) between the last three apertures (5) in order to serve as support faces for the ends of the reinforcing rods. The hollow body, containing the reinforcing rods, is filled with expanded plastic material. A reinforcing rod holder of this type is used in connection-type concreting operations and is advantageous in that, on the one hand, the portions of the reinforcing rods not embedded in concrete are packed in expanded plastics material and therefore cannot rust and, on the other hand, the expanded plastics material can be completely and conveniently removed by extracting the hollow body when the connection-type concreting operation is being carried out. In addition, the hollow body actually serves as a mould, thereby ensuring that the reinforcing rod holder is produced rationally and cheaply.
Patent AU-2243699-A (AU)
Title: Method for producing l-carnitine from crotonobetaine
Inventor: KLEBER HANS-PETER
IPC: C12P1/00
Filed: 1998-11-09
Abstract: L(-)-carnitine is synthesized from crotonobetaine, crotonobetaine salts or derivatives in an ecologically advantageous manner by immobilizing cells of Escherichia coli 044 K74 on ceramics, glass beads or polyurethane disks in a two stage continuously operating cell recycle reactor containing a reaction medium. The medium preferably contains between 25 mM and 1 M crotonobetaine and at least 50 mM fumarate. Growing or resting cells of E. coli are retained in the reactor by micro or ultrafiltration membranes which are arranged as a flat membrane module or hollow fiber module. A first stage contains a reactor tank and a second stage contains an external recirculation loop connected to the tank for feeding the reaction medium through a filter unit. L-carnitine is synthesized under anaerobic conditions to produce a reaction medium containing L-carnitine and unreacted crotonobetaine. The reaction medium is transferred through the recirculation loop to the filter unit to produce a filtrate containing L-carnitine and a residue containing unreacted crotonobetaine and cells. The residue is recirculated to the reactor tank.
Patent AU-2256097-A (AU)
Title: A g protein-coupled receptor with an enlarged extracellular domain
Inventor: YE RICHARD D
IPC: C07K14/72
Filed: 1997-01-30
Abstract: The invention features a G protein-coupled receptor that has an enlarged extracellular loop between the fourth and fifth transmembrane domains. A nucleic acid encoding the receptor was isolated from a human granulocytic cell library and antibodies generated against the polypeptide revealed expression in a variety of tissues including heart, placenta, and lung. This antibody, or others that specifically bind the G protein-coupled receptor of the invention, can be used in the diagnosis of diseases or conditions that are associated with upregulation of the receptor, as occurs, for example, when hematopoietic cells differentiate. These diseases include inflammatory and neurological diseases, particularly Alzheimer's Disease. The nucleic acids, polypeptides, and antibodies described herein can also be used as therapeutic agents to treat these diseases by inhibiting the expression or activity of the receptor. They can also be used in the treatment of obesity.
Patent AU-2317697-A (AU)
Title: Needle tip guard for hypodermic needles
Inventor: KURACINA THOMAS C
IPC: A61M5/24
Filed: 1997-02-27
Abstract: This invention is a needle tip protective device (22). In one embodiment the needle tip protective device (22) includes a needle guard (41) that is slidably mounted on a hypodermic needle (10) having a needle tip (11) located at the distal end of the needle (10). The needle guard (41) contains a movable needle trap (41) that is biased against or toward the hypodermic needle (10). The needle trap (41) advances over the tip (11) of the needle, entrapping the needle tip (11) as the needle guard (41) is urged forward near the sharpened distal end of the hypodermic needle (10). A tether (24), or other limiting means, limits the forward movement of the needle guard (41) along the needle (10). In one embodiment, the needle guard is manually urged forward along the shaft of the needle by the user. In yet another embodiment, a spring, or other biasing means (19), is used to move the needle guard (41) along the shaft of the needle (10).
Patent AU-2431101-A (AU)
Title: Processes for preparing clarithromycin polymorphs and novel polymorph iv
Inventor: LIFSHITZ IGOR
IPC: A61P31/04
Filed: 2000-12-15
Abstract: The present invention relates to processes for converting clarithromycin Form 0 to clarithromycin Form II, which include slurrying clarithromycin the Form 0 in water. The present invention also relates to processes for the preparation of clarithromycin Form II by converting erythromycin A to clarithromycin and thereafter converting clarithromycin Form 0 to clarithromycin Form II by slurrying. The present invention further relates to the novel clarithromycin polymorph Form IV, a process for its preparation, pharmaceutical compositions comprising the compound, and methods of using the compound as a therapeutic agent.
Patent AU-2484592-A (AU)
Title: Guard rail fittings
IPC: E04G21/32
Filed: 1992-08-26
Abstract: PCT No. PCT/SE92/00588 Sec. 371 Date Apr. 28, 1994 Sec. 102(e) Date Apr. 28, 1994 PCT Filed Aug. 26, 1992 PCT Pub. No. WO93/04249 PCT Pub. Date Mar. 4, 1993Fitting (1) for forming guard rails of posts or for anchoring guard elements with elongated guard elements, removably mounted in the fittings, such as boards, pipes, aluminum profiles or the like, or guard elements made as protective nets. The fitting (1) comprises an upper (2) and a lower (6) separate main component supporting individual guard elements. The ends (12, 34) of the components (2, 6) facing each other are each provided with a laterally extending lug (14, 36). The lugs are pivotably joined to each other and a clevis is pivotably mounted about the lugs (14, 36) and is provided with an anchoring pin (26) disposed essentially perpendicular to the pivot axis of the lugs.
Patent AU-2623100-A (AU)
Title: Transgenic systems for the manufacture of poly(3-hydroxy -butyrate-CO-3-hydroxyhexanoate)
Inventor: MADISON LARA
IPC: A01H5/00
Filed: 2000-01-21
Abstract: Methods for engineering transgenic organisms that synthesize polyhydroxyalkanoates (PHAs) containing 3-hydroxyhexanoate as comonomer have been developed. These processes are based on genetically engineered bacteria such as  Escherichia coli  or in plant crops as production systems which include PHA biosynthetic genes from PHA producers. In a preferred embodiment of the method, additional genes are introduced in wild type or transgenic polyhydroxybutyrate (PHB) producers, thereby creating new strains that synthesize 3HH monomers which are incorporated into PHAs. The 3HH monomer preferably is derived in microbial systems using butanol or butyrate as feedstocks, which are precursors of 3-hydroxyhexanoyl-CoA. Pathways for  in vivo  production of butyrol-CoA specifically encompassing butyryl-CoA dehydrogenase activity are provided.
Patent AU-2700488-A (AU)
Title: Pharmaceutical compositions containing dyclonine hcl and phenol
IPC: A61K31/445
Filed: 1988-12-16
Abstract: Novel pharmaceutical compositions of matter are disclosed for use in eliciting a topical anesthetic and antimicrobial response, preferably for oral health care purposes, said compositions comprising dyclonine hydrochloride and phenol. When used in combination, dyclonine hydrochloride and phenol provide an improved antimicrobial response.
Patent AU-2803695-A (AU)
Title: Assay for inhibitors of dp-1 and other dp proteins
Inventor: THANGUE NICHOLAS BARRIE LA
IPC: C12N15/02
Filed: 1995-07-03
Abstract: PCT No. PCT/GB95/01567 Sec. 371 Date Feb. 26, 1996 Sec. 102(e) Date Feb. 26, 1996 PCT Filed Jul. 3, 1995 PCT Pub. No. WO96/01425 PCT Pub. Date Jan. 18, 1996The protein DP-1, part of the DP-1/E2F-1 transcription factor complex, as well as DP-2 and DP-3 has its phosphorylation level regulated during cell cycle progression. This finding allows assays to be based on changes in phosphorylation of DP proteins, in particular for agents which may affect the phosphorylation state of DP. DP-1 has been found to have a greater affinity to DNA when in a hypophosphorylated state. Antibodies that recognize phosphorylation sites on DP-1 are also disclosed.
Patent AU-2875202-A (AU)
Title: Remote network management software
Inventor: HAGER GEOFFREY
IPC: H04L12/24
Filed: 2001-10-26
Abstract: A system and method is provided for remote administration and management of a computer network, by installation of distributed software agents in remote network components, such as software agents implemented using encapsulated reusable interfaces such as COM or CORBA interfaces. Remote network management is effected by communication with the distributed agents using a structured language-independent parsable text document, such as a markup language; e.g. XML.
Patent AU-2993899-A (AU)
Title: Improvements in the enzymatic synthesis of chiral amines
Inventor: WU WEI
IPC: C12P13/04
Filed: 1999-03-10
Abstract: 2-Aminopropane is used as the amine donor in the stereoselective synthesis of a chiral amine from a ketone with a transaminase. In a typical embodiment, (S)-1-methoxy-2-aminopropane is prepared by bringing methoxyacetone into contact with a transaminase in the presence of 2-aminopropane as an amine donor until a substantial amount of methoxyacetone is converted to (S)-1-methoxy-2-aminopropane and 2-aminopropane is converted to acetone. In a second embodiment, L-alanine is prepared by bringing pyruvic acid into contact with a transaminase in the presence of 2-aminopropane as an amine donor.
Patent AU-3083000-A (AU)
Title: System and method for conveying sheet-like objects
Inventor: RIJKEN JACOBUS
IPC: B65G51/02
Filed: 2000-01-05
Abstract: A system for conveying sheet-like objects, in particular banknotes, comprises a cash dispensing unit, a number of cash dispensing stations and a control unit. A conveying channel having an inlet side and an outlet side is disposed between the cash dispensing unit and each cash dispensing station, with elements for generating an air flow being present in each conveying channel. An enveloping device for enveloping the objects to be conveyed is disposed between the cash dispensing unit and the conveying channel(s). The cash dispensing unit delivers banknotes requested by a cash dispensing station to the enveloping device under the control of the control unit, which enveloping device envelopes the banknotes by a cash dispensing station and delivers the envelope to a unit for delivering the envelope containing banknotes to a conveying channel.
Patent AU-3144101-A (AU)
Title: Consumable authentication protocol and system
Inventor: WALMSLEY SIMON ROBERT
IPC: H04L9/32
Filed: 2001-02-15
Abstract: A method in which a test function is called in a system's internal authentication IC multiple times with a known incorrect value such that, if the internal IC is invalid, an expected invalid response is not generated and, otherwise, the internal IC generates a secret random number and its signature and encrypts these using a first secret key, an external authentication IC connected to the system calls a read function which decrypts the encrypted random number and signature using the first key, calculates the decrypted random number's signature, compares the signatures and upon a match encrypts the decrypted random number and a message of the external IC using a second secret key, the internal IC calls the test function which encrypts the random number and message using the second key, compares the encrypted random numbers and messages, validates the external IC if they match and invalidates the external IC otherwise.
Patent AU-3244399-A (AU)
Title: Device and method for in-mold compression and/or in-mold injection and for edging a decorative material with supporting material
Inventor: KAUFMANN GEORG
IPC: B29C45/14
Filed: 1999-03-17
Abstract: An apparatus and a process for the compression and/or injection in-mold lamination of a decorative material (1) and for the complete bordering of at least part of the edge (2) of this decorative material with a backing material (3) are proposed. The apparatus comprises at least two mold parts-forming a cavity (4). A first mold part (5) comprises pressing means (7) and a second mold part (6) comprises holding means (8) for holding a decorative material (1), placed into the cavity (4, 4'), at a distance from a surface (9) of the cavity formed by the second mold part (6), these holding means (8) being arranged raised with respect to this surface (9), entirely within the cavity (4, 4') and immovably with respect to the surface (9) of the latter. The apparatus is characterized in that the holding means (8) are arranged entirely within the cavity (4, 4') and immovably with respect to the surface (9) of the latter and in that the pressing means (7) are designed and arranged such that the decorative material (1) is pressed by them onto the holding means (8)-at least in the vicinity of the edge (2)-at least during the compression and/or injection in-mold lamination.
Patent AU-3248393-A (AU)
Title: Connection device with a pre-slit seal
Inventor: LARKIN MARK E
IPC: A61M39/00
Filed: 1992-12-09
Abstract: A connecting system is provided with a connector adapted to be mounted to the end of a conduit for removably engaging a blunt cannula to establish fluid communication between the conduit and cannula. The connector has a housing which defines a passage for communicating with the conduit and which defines an opening to the passage. The housing also defines a generally frustoconical seating surface which decreases in diameter in the direction toward the opening. A generally fluid-impervious, resilient seal is retained within the housing passage against the seating surface. The seal defines a slit which can accommodate penetration by the blunt cannula and which can reseal upon withdrawal of the blunt cannula.
Patent AU-3279893-A (AU)
Title: A device for handling of cables on seismic vessels
IPC: G01V1/38
Filed: 1992-07-23
Abstract: PCT No. PCT/NO92/00125 Sec. 371 Date Jan. 14, 1994 Sec. 102(e) Date Jan. 14, 1994 PCT Filed Jul. 23, 1992 PCT Pub. No. WO93/02371 PCT Pub. Date Feb. 4, 1993.A device to facilitate the handling, maintenance and replacement of seismic equipment and seismic energy sources in the gun arrangement section, i.e. the gun array of seismic gun cables on seismic survey vessels, on the vessel's after deck (1) by which the gun cables are transferred, with the arrays stored on the deck hanging in suspension rails (6), wherein the cable is wound up on to a number of drums (3) and deployed or recovered from the water over a slip (4) at the after end of the ship. On the deck there are also winch drums (5) for streamer cables. The gun cable drums (3) are placed in a row alongside one another athwartships. Also provided is a row of parallel tracks (6), suspended on rails which can be moved in a crosswise direction. The ends of the rails or tracks (6) are equipped with devices whereby they can be connected to transfer tracks (7) on the slip (4). The gun arrays in their tracks (6) can be moved athwartships, thus providing more working space and allowing better use to be made of the area available on the after deck.
Patent AU-3420495-A (AU)
Title: Control of oilfield biofouling
Inventor: HEGARTY BRYAN MARTIN
IPC: A01N43/80
Filed: 1995-10-11
Abstract: The invention describes a process for controlling contamination of oil production system waters by sessile bacteria, comprising   a) addition of a slug dose of a biologically effective amount of a quick-kill biocide, simultaneously with or followed by b) intermittent addition of a biologically effective amount of a control biocide.   This dosing regime is found to be surprisingly effective when compared with known dosing regimes.
Patent AU-3486795-A (AU)
Title: Apparatus for indicating correct or faulty back posture
Inventor: TRANAS RANDI HENDEN
IPC: A63B23/02
Filed: 1995-09-05
Abstract: The invention relates to a device (1) for placing on a person's head (2) to indicate correct or incorrect upright posture during the performance of various activities in a standing or sitting position. The device comprises a balance element consisting of a fixed body (4) which is firmly secured to a headband or similar for attachment to the head (2), and a moveable body (5) which is translationally moveable relative to the fixed body (4), essentially in a plane parallel to or coincident with the main plane of the fixed body (4), whereby the moveable body (5) is designed to move translationally relative to the fixed body (4) when a certain degree of deviation from the correct head position occurs.
Patent AU-3525095-A (AU)
Title: Deffective recombinant adenoviruses with inactivated iva2 gene
Inventor: ORSINI CECILE
IPC: A61K48/00
Filed: 1995-09-22
Abstract: The present invention relates to new viral vectors derived from adenoviruses, their preparation and utilization in gene therapy. It relates particularly to defective recombinant adenoviruses wherein the Iva2 gene at least is inactivated.
Patent AU-3526995-A (AU)
Title: Vaccine compositions
Inventor: CHATFIELD STEVEN NEVILLE
IPC: A61K47/36
Filed: 1995-09-21
Abstract: PCT No. PCT/GB95/02231 Sec. 371 Date Apr. 2, 1997 Sec. 102(e) Date Apr. 2, 1997 PCT Filed Sep. 21, 1995 PCT Pub. No. WO96/10421 PCT Pub. Date Apr. 11, 1996The invention relates to a vaccine composition adapted for mucosal administration, and in particular for intranasal administration, the composition comprising an influenza virus antigen or antigens, such as haemagglutinin and neuraminidase influenza virus antigens, and an effective adjuvant amount of a chitosan. The compositions can be used to immunise a host against infection with influenza, the chitosan serving to enhance the stimulation of a protective IgA mucosal immune response and an IgG systemic immune response.
Patent AU-3528399-A (AU)
Title: Non-fermented osmotic laxative for treating and preventing colorectal cancers
Inventor: CORPET DENIS E
IPC: A61K31/765
Filed: 1999-05-05
Abstract: Use of a non-fermented osmotic laxative as an active agent for preparation of a medicinal product for treating and/or preventing colon and/or rectum cancers. A method of treating or preventing colon or rectum cancer comprising administering to a mammal a therapeutically effective amount of a non-fermented osmotic laxative.
Patent AU-3595089-A (AU)
Title: Vortex tube separating device
Inventor: PRINSLOO WILLEM JOHANNES CHRIS
IPC: B01D45/12
Filed: 1989-06-01
Abstract: A vortex tube gas cleaning device 10 is used to clean a particle containing gas flow stream of particles. The device 10 has an outer tube 12 having an inlet 14 at an upstream end, and, in series downstream of the inlet 14, a vortex generator 16 in a vortex region 18, and a separation region 19. An inner extraction tube 40 is located at the downstream end of the tube 12 and extends concentrically within the outer tube 12, upstream, canti-lever fashion. A peripheral outlet region 22 is defined annularly around the inner tube 40 downstream of the separation region 19 and leads to an outlet port 36. A central outlet region 24 is defined within the inner tube 40 downstream of the separation region 19 and leads to an outlet 48. A ring 50 which is integral with the inner tube 40 extends into the outer peripheral region 22. It has an oblique leading wall 52 leading to a crown defining an annular orifice 54. The wall 52 forms an acceleration region via which flow in the region 22 is accelerated toward the annular orifice 54. The wall 52 commences spatially downstream of a leading edge of an inlet 42 into the tube 40. The leading edge blends into an aerodynamic lip 43.
Patent AU-3625693-A (AU)
Title: Process for coating the surface of elongated materials
Inventor: PARAMONOV VLADIMIR A
IPC: C23C2/38
Filed: 1993-03-04
Abstract: The invention is directed to a process and apparatus for coating the surface of elongated materials, in particular steel strips, with a metallic coating. The material is guided in one direction through a tank holding the molten coating material. The tank has a through-duct surrounded by an electric field below the surface of the molten bath. An electromagnetic force is generated in the region where the through-duct opens into the melt, which electromagnetic force is equal to or greater than the metallostatic pressure, directed oppositely thereto vectorially and quantitatively proportional to the product of the cross-sectional area of the inlet opening and the metallostatic pressure, and in which the dwell of the strip in the melt can be controlled independently of the rate of feed of the strip. The molten is constantly moved against the surface of the elongated material while the elongated material passes through it; and the molten material is circulated in a closed system, without contact to oxygen in the atmosphere.
Patent AU-3978095-A (AU)
Title: Heterocyclic compounds and their preparation and use
Inventor: OLESEN PREBEN HOULBERG
IPC: A61P25/18
Filed: 1995-11-20
Abstract: The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
Patent AU-3978500-A (AU)
Title: Magnetic materials
Inventor: COWBURN RUSSELL
IPC: H03K19/168
Filed: 2000-04-07
Abstract: A logic element comprises nanomagnets having a rotational symmetry around an axis selected such that they are superparamagnetic and exhibit substantially zero hysteresis so that a magnetisation of the nanomagnets depends only on the current value of applied field and not on the field history.
Patent AU-4045889-A (AU)
Title: Plastic pallet with deck assembly
Inventor: PIGOTT MAURICE J
IPC: B65D19/32
Filed: 1989-08-01
Abstract: A plastic pallet includes two identical decks (12) that are interconnected by identical connectors (14). Each connector includes a central core (20) and a surrounding sleeve (44) interconnected by spokes (46). The core has flexible tangs (26) that extend beyond opposite ends of the sleeve and lock onto the deck. <IMAGE>   <IMAGE>